Ligne de temps
Sylvain Baize
Responsable de Structure
10 août 2024
publication
High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population
Lire plus30 sept. 2023
12 sept. 2023
publication
Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model.
Lire plus11 mars 2023
publication
Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.
Lire plus01 janv. 2023
publication
A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates.
Lire plus01 déc. 2022
publication
Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys.
Lire plus21 mars 2022
publication
Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus.
Lire plus09 juin 2021
publication
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.
Lire plus04 janv. 2021
publication
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.
Lire plus02 oct. 2019
publication
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.
Lire plus10 janv. 2019
27 juil. 2015
21 juil. 2015
publication
Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement
Lire plus19 juil. 2015
03 juil. 2015
11 mai 2015
06 févr. 2015
publication
Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus
Lire plus01 janv. 2015
publication
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014
Lire plus24 nov. 2014
publication
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014
Lire plus19 nov. 2014
24 sept. 2014
publication
Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response
Lire plus24 sept. 2014
publication
The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses
Lire plus16 avr. 2014
27 févr. 2014
publication
Anjozorobe hantavirus, a new genetic variant of Thailand virus detected in rodents from Madagascar
Lire plus09 janv. 2014
publication
Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever
Lire plus25 avr. 2013
05 nov. 2012
31 août 2011
publication
Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages
Lire plus01 juil. 2011
publication
Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa
Lire plus01 oct. 2010
20 mars 2006
publication
Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages
Lire plus01 oct. 2004
publication